Lack of immune responses against multiple sclerosis–associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis

References

• Antony J M, Ellestad K K, Hammond R, Imaizumi K, Mallet F, Warren K G, Power C. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J Immunol 2007; 179: 1210–1224
   PubMedGoogle Scholar
• Antony J M, Izad M, Bar-Or A, Warren K G, Vodjgani M, Mallet F, Power C. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res Hum Retroviruses 2006; 22: 1253–1259
   PubMedGoogle Scholar
• Antony J M, van Marle G, Opii W, Butterfield D A, Mallet F, Yong V W, Wallace J L, Deacon R M, Warren K, Power C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004; 7: 1088–1095
   PubMed Web of Science ®Google Scholar
• Blond J-L, Beseme F, Duret L, Bouton O, Bedin F, Perron H, Mandrand B, Mallet F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999; 73: 1175–1185
   PubMed Web of Science ®Google Scholar
• Blond J-L, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F, Cosset F L. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000; 74: 3321–3329
   PubMed Web of Science ®Google Scholar
• Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K, Mueller-Lantzsch N. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 2000; 19: 4328–4336
   Google Scholar
• Boller K, Janssen O, Schuldes H, Tonjes R R, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997; 71: 4581–4588
   PubMed Web of Science ®Google Scholar
• Cheynet V, Ruggieri A, Oriol G, Blond J L, Boson B, Vachot L, Verrier B, Cosset F L, Mallet F. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J Virol 2005; 79: 5585–5593
   Google Scholar
• Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15: 179–211
   PubMed Web of Science ®Google Scholar
• de Parseval N, Heidmann T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res 2005; 110: 318–332
   PubMed Web of Science ®Google Scholar
• Dolei A, Serra C, Mameli G, Pugliatti M, Sechi G, Cirotto M C, Rosati G, Sotgiu S. Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 2002; 58: 471–473
   PubMed Web of Science ®Google Scholar
• Firouzi R, Rolland A, Michel M, Jouvin-Marche E, Hauw J J, Malcus-Vocanson C, Lazarini F, Gebuhrer L, Seigneurin J M, Touraine J L, Sanhadji K, Marche P N, Perron H. Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J NeuroVirol 2003; 9: 79–93
   PubMed Web of Science ®Google Scholar
• Garson J A, Tuke P W, Giraud G, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998; 351: 33
   PubMed Web of Science ®Google Scholar
• Gronen F, Ruprecht K, Weissbrich B, Klinker E, Kroner A, Hofstetter H, Rieckmann P. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 2006; 180: 185–192
   PubMed Web of Science ®Google Scholar
• Hill A, Worth A, Elliott T, Rowland-Jones S, Brooks J, Rickinson A, McMichael A. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur J Immunol 1995; 25: 18–24
   Google Scholar
• Kidd I M, Emery V C. The use of baculoviruses as expression vectors. Appl Biochem Biotechnol 1993; 42: 137–159
   PubMedGoogle Scholar
• Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, Ott C, Rajoharison A, Garcia E, Mallet F, Mandrand B, Perron H. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 1999; 260: 1–9
   PubMed Web of Science ®Google Scholar
• Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 2007; 88: 264–274
   Google Scholar
• Mattson M P, Taub D D. Ancient viral protein enrages astrocytes in multiple sclerosis. Nat Neurosci 2004; 10: 1021–1023
   Google Scholar
• Noseworthy J H. Progress in determining the causes and treatment of multiple sclerosis. Nature 1999; 399: A40–A47
   PubMed Web of Science ®Google Scholar
• Nowak J, Januszkiewicz D, Pernak M, Liwen I, Zawada M, Rembowska J, Nowicka K, Lewandowski K, Hertmanowska H, Wender M. Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients. J NeuroVirol 2003; 9: 112–117
   PubMed Web of Science ®Google Scholar
• Ortin A, Minguijon E, Dewar P, Garcia M, Ferrer L M, Palmarini M, Gonzalez L, Sharp J M, De las Heras M. Lack of a specific immune response against a recombinant capsid protein of jaagsiekte sheep retrovirus in sheep and goats naturally affected by enzootic nasal tumour or sheep pulmonary adenomatosis. Vet Immunol Immunopathol 1998; 61: 229–237
   Google Scholar
• Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998; 16: 323–358
   PubMed Web of Science ®Google Scholar
• Perron H, Garson J A, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke P W, Voisset C, Blond J L, Lalande B, Seigneurin J M, Mandrand B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci U S A 1997; 94: 7583–7588
   PubMed Web of Science ®Google Scholar
• Perron H, Geny C, Laurent A, Mouriquand C, Pellat J, Perret J, Seigneurin J M. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140: 551–561
   PubMedGoogle Scholar
• Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, Mallaret M, Schuller E, Stoebner P, Seigneurin J M. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991; 337: 862–863
   PubMed Web of Science ®Google Scholar
• Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, Sazdovitch V, Creange A, Battail-Poirot N, Sibai G, Santoro L, Jolivet M, Darlix J-L, Rieckmann P, Arzberger T, Hauw J-J, Lassmann H. Human endogenous retrovirus (HERV)-W env and gag proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J NeuroVirol 2005; 11: 23–33
   PubMed Web of Science ®Google Scholar
• Poser C M, Paty D W, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Kuebler P J, Heymann J J, Sheehy M E, Ortiz G M, Ogg G S, Barbour J D, Lenz J, Steinfeld A D, Nixon D F. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res Hum Retroviruses 2006; 22: 52–56
   Google Scholar
• Rammensee H-G, Bachmann J, Emmerich N N, Bachor O A, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213–219, http://www.syfpeithi.de access via
   PubMed Web of Science ®Google Scholar
• Rammensee H-G, Bachmann J, Stevanovic S. MHC ligands and peptide motifs. Landes, Austin, TX 1997
   Google Scholar
• Ruprecht K, Obojes K, Wengel V, Gronen F, Kim K S, Perron H, Schneider-Schaulies J, Rieckmann P. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J NeuroVirol 2006; 12: 65–71
   PubMed Web of Science ®Google Scholar
• Sauter M, Schommer S, Kremmer E, Remberger K, Dolken G, Lemm I, Buck M, Best B, Neumann-Haefelin D, Mueller-Lantzsch N. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995; 69: 414–421
   PubMed Web of Science ®Google Scholar
• Schiavetti F, Thonnard J, Colau D, Boon T, Coulie P G. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res 2002; 62: 5510–5516
   PubMed Web of Science ®Google Scholar
• Sotgiu S, Arru G, Mameli G, Serra C, Pugliatti M, Rosati G, Dolei A. Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a sardinian cohort. Mult Scler 2006; 12: 698–703
   PubMed Web of Science ®Google Scholar
• Spencer T E, Mura M, Gray C A, Griebel P J, Palmarini M. Receptor usage and fetal expression of ovine endogenous betaretroviruses: implications for coevolution of endogenous and exogenous retroviruses. J Virol 2003; 77: 749–753
   Google Scholar
• Voisset C, Bouton O, Bedin F, Duret L, Mandrand B, Mallet F, Paranhos-Baccala G. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retroviruses 2000; 16: 731–740
   PubMed Web of Science ®Google Scholar